Skip to content

Observation on the Anesthetic Effect of Ciprofol in Elderly Patients with Atrial Fibrillation

Effects of Ciprofol on Hemodynamics During Anesthesia Induction in Elderly Patients with Atrial Fibrillation Undergoing Non-cardiac Surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600131285
Enrollment
Unknown
Registered
2026-08-31
Start date
2026-08-31
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Ciprofol group:Anesthesia Induction with Ciprofol

Sponsors

THE SECOND PEOPLE'S HOSPITAL,WUHU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years old, regardless of gender; 2. Preoperatively confirmed diagnosis of atrial fibrillation, with concomitant left ventricular diastolic dysfunction verified by echocardiography; 3. American Society of Anesthesiologists (ASA) physical status classification II-III; 4. Scheduled for elective non-cardiac surgery under general anesthesia; 5. Well-controlled preoperative blood pressure: systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg; 6. Voluntary written informed consent signed by the patient or legal representative.

Exclusion criteria

Exclusion criteria: 1. Left ventricular ejection fraction < 50% with severe left ventricular systolic dysfunction; 2. Acute heart failure or myocardial infarction within the past 3 months; 3. Atrial fibrillation combined with third-degree atrioventricular block or sick sinus syndrome, with a cardiac pacemaker implanted or pending implantation; 4. History of allergy to propofol, ciprofol and other anesthetics used in this study; 5. Combined severe hepatic and renal insufficiency (Child-Pugh Class C, renal failure requiring dialysis); 6. Coagulopathy or active bleeding tendency; 7. Mental illness or cognitive dysfunction that prevents cooperation with the study and follow-up visits; 8. Pregnant or breastfeeding women; 9. Emergency surgery, major vascular surgery, or estimated operation duration exceeding 6 hours; 10. Use of investigational drugs affecting cardiovascular function within the past 1 month, or current participation in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Incidence of hypotension during anesthesia induction;Systolic blood pressure, diastolic blood pressure, heart rate;

Secondary

MeasureTime frame
Bispectral index (BIS) value;Onset time of anesthesia induction, intubation condition score;Incidence of adverse reactions including bradycardia, hypertension, coughing, nausea and vomiting;Postoperative recovery time and tracheal extubation time;

Countries

China

Contacts

Public ContactYing Zhao

THE SECOND PEOPLE'S HOSPITAL,WUHU

zhao.ying-2001@163.com+86 553 3909017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026